According to our (Global Info Research) latest study, the global Mechanical Circulatory Support Device market size was valued at US$ 2265 million in 2025 and is forecast to a readjusted size of US$ 3962 million by 2032 with a CAGR of 8.4% during review period.
Mechanical Circulatory Support (MCS) devices are life-saving medical technologies designed to assist or replace the pumping function of the failing heart in patients with advanced heart failure. These devices include ventricular assist devices (VADs), total artificial hearts (TAHs), and extracorporeal membrane oxygenation (ECMO) systems. MCS devices are used as bridge-to-transplant, bridge-to-recovery, or destination therapy in cases where pharmacologic management is no longer sufficient. The global average selling price for mechanical circulatory support devices is approximately US$85,000 per unit. The average sales volume in the base year is estimated at 25.9k units. The industry average gross margin is approximately 65%, with typical ranges between 55% and 75%, reflecting the high-precision engineering, proprietary technology, and significant clinical value of these life-saving devices. The upstream segment includes manufacturers of precision pumps, magnetic levitation systems, biocompatible materials, sensors, and electronic control systems. The midstream segment comprises device manufacturers that design, assemble, sterilize, and certify complete MCS systems. The downstream segment encompasses hospitals, cardiac surgery centers, and specialized cardiovascular care facilities where these devices are used for advanced heart failure management.
The mechanical circulatory support device market is experiencing significant transformation driven by the convergence of technological innovation, demographic shifts, and evolving clinical paradigms. The increasing prevalence of heart failure due to aging populations, ischemic heart disease, and cardiomyopathies is driving global clinical demand for MCS technologies. With heart transplants remaining severely limited by donor organ scarcity, MCS devices have become an essential alternative for long-term support and bridge-to-transplant cases. Recent innovations in mechanical and materials engineering have led to the development of next-generation devices that are smaller, more durable, and less prone to complications like thrombosis, bleeding, or infection. Continuous-flow pumps, magnetically levitated impellers, and wireless energy transfer systems are redefining patient outcomes by improving hemodynamic stability with reduced surgical burden. Wearable driveline systems and fully implantable prototypes are improving patient mobility and quality of life, facilitating outpatient management and long-term use. On the clinical front, integration of real-time hemodynamic monitoring, remote telemetry, and AI-assisted data interpretation is enhancing decision-making and post-implantation care. Multidisciplinary heart failure teams are implementing patient-tailored MCS protocols supported by advanced imaging and risk stratification tools, reducing hospitalization time and expanding adoption in tertiary care centers worldwide. The shift from traditional pulsatile flow devices to continuous-flow systems represents a fundamental evolution in pump design, enabling smaller implants and longer device durability. As heart failure becomes a leading cause of morbidity and mortality worldwide, demand for mechanical support is expected to grow steadily.
This report is a detailed and comprehensive analysis for global Mechanical Circulatory Support Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mechanical Circulatory Support Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mechanical Circulatory Support Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mechanical Circulatory Support Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mechanical Circulatory Support Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mechanical Circulatory Support Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mechanical Circulatory Support Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Getinge, Teleflex, MERA, Johnson & Johnson (Abiomed), RocorMed (RocketHeart Technology), Abbott, Suzhou Tongxin Medical, Medtronic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mechanical Circulatory Support Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
IABP
ECMO
Impella
Other
Market segment by Support Duration
Short-Term Support (< 30 Days)
Long-Term/Durable Support (> 30 Days)
Market segment by Flow Type
Pulsatile Flow Devices
Continuous Flow Devices
Market segment by Application
Hospital
Cardiac Care Center
Other
Major players covered
Getinge
Teleflex
MERA
Johnson & Johnson (Abiomed)
RocorMed (RocketHeart Technology)
Abbott
Suzhou Tongxin Medical
Medtronic
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mechanical Circulatory Support Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mechanical Circulatory Support Device, with price, sales quantity, revenue, and global market share of Mechanical Circulatory Support Device from 2021 to 2026.
Chapter 3, the Mechanical Circulatory Support Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mechanical Circulatory Support Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mechanical Circulatory Support Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mechanical Circulatory Support Device.
Chapter 14 and 15, to describe Mechanical Circulatory Support Device sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Mechanical Circulatory Support Device. Industry analysis & Market Report on Mechanical Circulatory Support Device is a syndicated market report, published as Global Mechanical Circulatory Support Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Mechanical Circulatory Support Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.